Developmental states of localised and metastatic osteosarcoma cells – a knowledge bank for novel biomarkers and therapeutic approachesDr Sam Behjati, Wellcome Sanger Institute
Risk stratification of the national population of survivors of childhood, teenage and young adult cancer for evidence-based clinical follow-upProfessor Michael Hawkins, Centre for Childhood Cancer Survivor Studies, University of Birmingham
Assessment of potential health impacts from transplacental exposure to carcinogenic air pollutants.Professor Dudley Shallcross, University of Bristol
Early exposure to radio-frequency electromagnetic fields and cancer: complete evaluation of the Ramazzini Institute long-term carcinogenicity bioassaysDr Fiorella Belpoggi, Ramazzini Institute
Investigating metabolic mechanisms driving childhood brain cancerProfessor Thomas Seyfried, Massachusetts, USA
Cancer risk in childhood cancer survivors (CRICCS): understanding the causes to target preventionDr Eva Steliarova-Foucher, International Agency for Research on Cancer (IARC)
One of the greatest medical success stories of the last century is the amazing growth in the survival from childhood cancer. Fifty years ago, only a quarter of children diagnosed with cancer survived. Today, more than 80 per cent of young patients can be successfully treated.
However, cancer still claims the lives of around 250 children every year in the UK. And unfortunately the children who survive may be left with serious health and developmental problems as a result of the intensive treatments used to save their young lives.
Through our investment in research, we are taking forward our understanding of childhood cancer, to give new insights into ways of treating young patients with even the most difficult forms of cancer. We hope to drive up the survival rate still further whilst reducing the risk of harm.